Summary & Overview
HCPCS Level II K1028: Power Unit for Oral Tongue Neuromuscular Stimulation
HCPCS Level II code K1028 identifies the power source and control electronics unit for an oral appliance used to deliver neuromuscular electrical stimulation to the tongue muscle, with control via a phone application. As a device-level HCPCS code, K1028 matters nationally because it defines a billable durable medical equipment (DME) component linked to devices addressing dysphagia, tongue dysfunction, and related neuromuscular disorders. Coverage and reimbursement for such components affect access to therapy that may support swallowing function and speech rehabilitation.
Key payers considered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the code’s clinical role, common care settings where the unit is used, and the payer landscape that typically applies to DME and device component claims. The publication also summarizes benchmark considerations, relevant billing modifiers and claim-handling nuances, and the clinical context in which the device is prescribed and deployed. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code K1028 describes a power source and control electronics unit for an oral device or appliance that delivers neuromuscular electrical stimulation of the tongue muscle, with operation controlled by a phone application. This device component supplies power, houses control circuitry, and interfaces with a user application to adjust stimulation parameters.
-
Service type: Durable medical equipment component for neuromuscular electrical stimulation therapy
-
Typical site of service: Use with an oral appliance in outpatient clinics, speech-language pathology settings, rehabilitation centers, or home use when prescribed and fitted by a qualified clinician
Clinical & Coding Specifications
Clinical Context
A 62-year-old patient with chronic oropharyngeal dysphagia and tongue weakness following a stroke is evaluated in an outpatient multidisciplinary swallowing clinic. The team includes a speech-language pathologist and a physiatrist or ear‑nose‑throat physician. After bedside and instrumental swallowing assessments (including videofluoroscopic swallow study), the clinician determines the patient may benefit from neuromuscular electrical stimulation targeted to the genioglossus and other tongue muscles to improve tongue strength and bolus control.
The device indicated is a power source and control electronics unit for an oral appliance that delivers neuromuscular electrical stimulation to the tongue and is controlled via a smartphone application (K1028). The clinical workflow includes device selection and programming by the clinician, patient education on device use and app pairing, oral appliance fitting by the dental lab or durable medical equipment provider, an initial monitored stimulation and therapy session in clinic, and periodic follow-up visits to assess progress and adjust parameters. Typical sites of service are outpatient clinic, speech-language pathology clinic, or home use after training. Documentation includes indication (diagnosis of dysphagia with tongue weakness), informed consent, device settings, app pairing confirmation, time spent on training, and functional swallowing outcomes.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 |